Metropolitan Bank and Trust Company:企業の戦略・SWOT・財務情報

◆英語タイトル:Metropolitan Bank and Trust Company - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C11741
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィリピン
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Metropolitan Bank and Trust Company – Strategy, SWOT and Corporate Finance Report
Summary

Metropolitan Bank and Trust Company – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Metropolitan Bank and Trust Company (Metrobank or ‘the company’ or ‘the bank’) offers a full range of banking and other financial products and services, including corporate, commercial and consumer banking, as well as credit card, remittances, leasing, investment banking and trust banking. The company operates in Asia Pacific, Europe, the Middle East, and the Americas. It is headquartered in Makati City, the Philippines.

Scope

- Detailed information on Metropolitan Bank and Trust Company required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Metropolitan Bank and Trust Company in the form of a SWOT analysis
- An in-depth view of the business model of Metropolitan Bank and Trust Company including a breakdown and examination of key business segments
- Intelligence on Metropolitan Bank and Trust Company’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Metropolitan Bank and Trust Company, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Metropolitan Bank and Trust Company and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Metropolitan Bank and Trust Company as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Metropolitan Bank and Trust Company’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Metropolitan Bank and Trust Company: Company Overview 9
Metropolitan Bank and Trust Company: Overview and Key Facts 9
Metropolitan Bank and Trust Company: Overview 9
Metropolitan Bank and Trust Company: Key Facts 9
Metropolitan Bank and Trust Company: Key Employees 11
Metropolitan Bank and Trust Company: Key Employee Biographies 13
Metropolitan Bank and Trust Company: Major Products and Services 18
Metropolitan Bank and Trust Company: Company History 20
Metropolitan Bank and Trust Company: Management Statement 22
Metropolitan Bank and Trust Company: Locations and Subsidiaries 25
Metropolitan Bank and Trust Company: Key Competitors 27
Metropolitan Bank and Trust Company: Company Analysis 28
Metropolitan Bank and Trust Company: Business Description 28
Metropolitan Bank and Trust Company: SWOT Analysis 29
Metropolitan Bank and Trust Company: SWOT Overview 29
Metropolitan Bank and Trust Company: Strengths 29
Metropolitan Bank and Trust Company: Weaknesses 30
Metropolitan Bank and Trust Company: Opportunities 30
Metropolitan Bank and Trust Company: Threats 31
Metropolitan Bank and Trust Company: Corporate Financial Deals Activity 33
Metropolitan Bank and Trust Company: Financial Deals Overview 33
Metropolitan Bank and Trust Company: Targets and Partners 35
Metropolitan Bank and Trust Company: Top Deals 2014 – 2018YTD* 36
Metropolitan Bank and Trust Company: Advisors 37
Metropolitan Bank and Trust Company: Top Financial Advisors 37
Metropolitan Bank and Trust Company: Mergers and Acquisitions 38
Metropolitan Bank and Trust Company: Capital Raising 39
Metropolitan Bank and Trust Company: Private Equity and Ownership 40
Metropolitan Bank and Trust Company: Recent Developments 41
Metropolitan Bank and Trust Company: News and Events Summary 41
Metropolitan Bank and Trust Company: Business Expansion 41
Metropolitan Bank and Trust Company: Financial Deals 42
Metropolitan Bank and Trust Company: Financial Performance 43
Metropolitan Bank and Trust Company: Strategy and Operations 43
Appendix 45
Contact Us 45
Methodology 45
About MarketLine 46

List of Tables
Table 1: Metropolitan Bank and Trust Company: Key Facts
Table 2: Metropolitan Bank and Trust Company: Key Employees
Table 3: Metropolitan Bank and Trust Company: Company History
Table 4: Metropolitan Bank and Trust Company: Locations and Subsidiaries
Table 5: Metropolitan Bank and Trust Company: Key Competitors
Table 6: Metropolitan Bank and Trust Company: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Metropolitan Bank and Trust Company: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Metropolitan Bank and Trust Company: M&A Average Deal Size - Value (US$m)
Table 9: Metropolitan Bank and Trust Company: Targets and Partners
Table 10: Metropolitan Bank and Trust Company: Top Deals 2014 - 2018YTD*
Table 11: Metropolitan Bank and Trust Company: Financial Advisor Ranking by Value (US$m)
Table 12: Metropolitan Bank and Trust Company: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Metropolitan Bank and Trust Company: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Metropolitan Bank and Trust Company: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 15: Metropolitan Bank and Trust Company: Capital Raising by Deal Type (2014 - YTD*2018)
Table 16: Metropolitan Bank and Trust Company: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 17: Metropolitan Bank and Trust Company: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 18: Metropolitan Bank and Trust Company: News and Events Summary
Table 19: Metropolitan Bank and Trust Company: Business Expansion
Table 20: Metropolitan Bank and Trust Company: Financial Deals
Table 21: Metropolitan Bank and Trust Company: Financial Performance
Table 22: Metropolitan Bank and Trust Company: Strategy and Operations

List of Figures
Figure 1: Metropolitan Bank and Trust Company: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Metropolitan Bank and Trust Company: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Metropolitan Bank and Trust Company: M&A Average Deal Size - Value (US$m)
Figure 4: Metropolitan Bank and Trust Company: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Metropolitan Bank and Trust Company: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Metropolitan Bank and Trust Company: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 7: Metropolitan Bank and Trust Company: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 8: Metropolitan Bank and Trust Company: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 9: Metropolitan Bank and Trust Company: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Metropolitan Bank and Trust Company:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Korea Gas Corp (036460):企業の財務・戦略的SWOT分析
    Korea Gas Corp (036460) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Tsumura & co (4540):企業の財務・戦略的SWOT分析
    Tsumura & co (4540) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • ATS Automation Tooling Systems Inc (ATA):企業の財務・戦略的SWOT分析
    ATS Automation Tooling Systems Inc (ATA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Curtiss-Wright Corporation (CW)-石油・ガス分野:企業M&A・提携分析
    Summary Curtiss-Wright Corporation (Curtiss-Wright) is a diversified industrial company. It designs, manufactures and overhauls precision components and provides highly engineered and critical-function products, systems and services. Its offerings include sensor handling systems, surface technology …
  • Mega Uranium Ltd (MGA):企業の財務・戦略的SWOT分析
    Mega Uranium Ltd (MGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Oxford Immunotec Ltd:企業の製品パイプライン分析2018
    Summary Oxford Immunotec Ltd (Oxford Immunotec) a subsidiary of Oxford Immunotec Global Plc is a medical device company that offers proprietary tests for immune-regulated conditions. The company offers in vitro diagnostic, T-SPOT CMV Test, C6 Lyme ELISA Test, T-Cell Xtend Reagent. It offers T-SPOT.T …
  • PT Dahana:企業の戦略・SWOT・財務情報
    PT Dahana - Strategy, SWOT and Corporate Finance Report Summary PT Dahana - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Strategic Oil & Gas Ltd (SOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Strategic Oil & Gas Ltd (Strategic Oil & Gas) is an upstream oil and gas exploration and development company. The company acquires, explores, operates, manages, and develops crude oil and natural gas assets. It holds interests and operates its oil and gas exploration projects such as Marlowe …
  • Next Plc:企業の戦略・SWOT・財務情報
    Next Plc - Strategy, SWOT and Corporate Finance Report Summary Next Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Colonial Pipeline Company:石油・ガス:M&Aディール及び事業提携情報
    Summary Colonial Pipeline Company (Colonial) is an oil and gas company that distributes petroleum products. The company transports refined petroleum products such as gasoline, home-heating oil, kerosene, diesel fuels; and aviation fuel including jet fuel and military fuels. It provides services incl …
  • Merz Pharma GmbH & Co KgaA:医療機器:M&Aディール及び事業提携情報
    Summary Merz Pharma GmbH & Co KgaA (Merz Pharma) is an aesthetics and neurotoxin company that develops products for aesthetic and medical dermatology and neurological movement disorders. The company’s products include aesthetics, ethical drugs, over-the-counter drugs, neurology, and central nervous …
  • Brighthouse Financial, Inc. (BHF):企業の財務・戦略的SWOT分析
    Brighthouse Financial, Inc. (BHF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • BELLUS Health Inc (BLU):製薬・医療:M&Aディール及び事業提携情報
    Summary BELLUS Health Inc (BELLUS Health) is a biopharmaceutical development company, which focuses on developing drugs for rare diseases. The company’s pipeline products include BLU-5937 for chronic cough, Shigamab for STEC related hemolytic syndrome (sHUS); KIACTA for the treatment of a second ind …
  • Novartis Institutes for BioMedical Research Inc-製薬・医療分野:企業M&A・提携分析
    Summary Novartis Institutes for BioMedical Research Inc (NIBR), a subsidiary of Novartis AG is a medical research institute that offers treatment research and development programs. The institute offers clinical research services in areas of immuno-oncology, oncology, neuroscience, cardiovascular and …
  • Australian Leaders Fund Limited:企業の戦略・SWOT・財務分析
    Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • G. Siempelkamp GmbH & Co KG:企業の戦略的SWOT分析
    G. Siempelkamp GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • mixi, Inc.:企業の戦略・SWOT・財務情報
    mixi, Inc. - Strategy, SWOT and Corporate Finance Report Summary mixi, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Banco Angolano de Investimentos, SA:企業の戦略・SWOT・財務情報
    Banco Angolano de Investimentos, SA - Strategy, SWOT and Corporate Finance Report Summary Banco Angolano de Investimentos, SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Panoptes Pharma GesmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Panoptes Pharma GesmbH (Panoptes Pharma) is a biotech company that develops small molecule based therapies to treat severe eye diseases. The company also develops products in the therapeutic areas of uveitis, viral conjunctivitis, and further indications. It concentrates on a new treatment f …
  • Profire Energy Inc (PFIE):企業の財務・戦略的SWOT分析
    Summary Profire Energy Inc (Profire Energy) is an oilfield technology company that undertakes design, development, and installation of combustion management technology and chemical injection solutions. The company offers products such as burner management systems and chemical management systems. Its …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆